Skip to main content
. 2016 Nov 29;25(3):628–636. doi: 10.1016/j.jfda.2016.10.011

Table 1.

Effects of LCBs on body weight, serum inflammatory cytokines, and serum and hepatic ROS and FFAs concentrations in obese mice.

Control HFFD 0.008% LCBs 0.025% LCBs
Body weight gain (g) 15.5 ± 1.7 28.6 ± 2.1## 24.0 ± 2.3 18.6 ± 1.1**
Epididymal adipose weight (g) 0.554 ± 0.083 1.67 ± 0.20## 1.35 ± 0.22 0.868 ± 0.127**
Serum TNF-α (pg/mL) 287 ± 13 536 ± 30## 479 ± 25* 304 ± 19**
Serum CRP (ng/mL) 92.3 ± 6.6 137 ± 18## 124 ± 10 102 ± 8*
Serum MIP-1 (pg/mL) 28.9 ± 1.4 56.3 ± 3.4## 50.4 ± 2.1 36.6 ± 2.4**
Serum IL-1β (pg/mL) 54.3 ± 6.1 71.8 ± 4.4## 67.5 ± 3.7 62.2 ± 4.1*
Serum IL-6 (pg/mL) 32.9 ± 3.7 52.5 ± 4.4## 47.7 ± 3.6 41.1 ± 2.4**
Serum IL-10 (pg/mL) 122 ± 7 70.1 ± 5.7## 102 ± 7* 91.8 ± 8.5**
Serum ROS (U/mL) 164 ± 8 258 ± 13## 233 ± 11 189 ± 6**
Serum FFAs (μmol/L) 236 ± 14 376 ± 20## 315 ± 12* 270 ± 10**
Hepatic ROS (U/mg) 48.0 ± 3.1 97.2 ± 6.7## 83.8 ± 6.2 60.4 ± 5.3**
Hepatic FFAs (μmol/mg) 0.449 ± 0.016 1.38 ± 0.09## 1.16 ± 0.11 0.735 ± 0.039**

The obesity model mice were established by fed HFFD. Data are presented as mean ± standard deviation (n = 12/group). Multiple comparisons were done using one way ANOVA.

##

p < 0.01 versus control;

*

p < 0.05,

**

p < 0.01 versus HFFD.

CRP = C-reactive protein; FFA = free fatty acid; HFFD = high-fat fructose diet; IL = interleukin; LCBs = long-chain bases; MIP = macrophage inflammatory protein; ROS = reactive oxygen species; TNF = tumor necrosis factor-α.